- call +1-201-465-4211
- email sales@mrinsights.biz
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-Synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.
According to this study, over the next five years the Paclitaxel market will register a 9.0% CAGR in terms of revenue, the global market size will reach US$ 140 million by 2024, from US$ 90 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Paclitaxel business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel market by product type, application, key manufacturers and key regions and countries.
This study considers the Paclitaxel value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Paclitaxel consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Paclitaxel market by identifying its various subsegments.
Focuses on the key global Paclitaxel manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Paclitaxel with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Paclitaxel submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Paclitaxel Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paclitaxel Consumption 2014-2024
2.1.2 Paclitaxel Consumption CAGR by Region
2.2 Paclitaxel Segment by Type
2.2.1 Natural Paclitaxel API
2.2.2 Semi-synthetic Paclitaxel API
2.3 Paclitaxel Consumption by Type
2.3.1 Global Paclitaxel Consumption Market Share by Type (2014-2019)
2.3.2 Global Paclitaxel Revenue and Market Share by Type (2014-2019)
2.3.3 Global Paclitaxel Sale Price by Type (2014-2019)
2.4 Paclitaxel Segment by Application
2.4.1 Ovarian Cancer
2.4.2 Cervical Cancer
2.4.3 Breast Cancer
2.4.4 Other
2.5 Paclitaxel Consumption by Application
2.5.1 Global Paclitaxel Consumption Market Share by Application (2014-2019)
2.5.2 Global Paclitaxel Value and Market Share by Application (2014-2019)
2.5.3 Global Paclitaxel Sale Price by Application (2014-2019)
3 Global Paclitaxel by Players
3.1 Global Paclitaxel Sales Market Share by Players
3.1.1 Global Paclitaxel Sales by Players (2017-2019)
3.1.2 Global Paclitaxel Sales Market Share by Players (2017-2019)
3.2 Global Paclitaxel Revenue Market Share by Players
3.2.1 Global Paclitaxel Revenue by Players (2017-2019)
3.2.2 Global Paclitaxel Revenue Market Share by Players (2017-2019)
3.3 Global Paclitaxel Sale Price by Players
3.4 Global Paclitaxel Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Paclitaxel Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Paclitaxel Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Paclitaxel by Regions
4.1 Paclitaxel by Regions
4.1.1 Global Paclitaxel Consumption by Regions
4.1.2 Global Paclitaxel Value by Regions
4.2 Americas Paclitaxel Consumption Growth
4.3 APAC Paclitaxel Consumption Growth
4.4 Europe Paclitaxel Consumption Growth
4.5 Middle East & Africa Paclitaxel Consumption Growth
5 Americas
5.1 Americas Paclitaxel Consumption by Countries
5.1.1 Americas Paclitaxel Consumption by Countries (2014-2019)
5.1.2 Americas Paclitaxel Value by Countries (2014-2019)
5.2 Americas Paclitaxel Consumption by Type
5.3 Americas Paclitaxel Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Paclitaxel Consumption by Countries
6.1.1 APAC Paclitaxel Consumption by Countries (2014-2019)
6.1.2 APAC Paclitaxel Value by Countries (2014-2019)
6.2 APAC Paclitaxel Consumption by Type
6.3 APAC Paclitaxel Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Paclitaxel by Countries
7.1.1 Europe Paclitaxel Consumption by Countries (2014-2019)
7.1.2 Europe Paclitaxel Value by Countries (2014-2019)
7.2 Europe Paclitaxel Consumption by Type
7.3 Europe Paclitaxel Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Paclitaxel by Countries
8.1.1 Middle East & Africa Paclitaxel Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Paclitaxel Value by Countries (2014-2019)
8.2 Middle East & Africa Paclitaxel Consumption by Type
8.3 Middle East & Africa Paclitaxel Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Paclitaxel Distributors
10.3 Paclitaxel Customer
11 Global Paclitaxel Market Forecast
11.1 Global Paclitaxel Consumption Forecast (2019-2024)
11.2 Global Paclitaxel Forecast by Regions
11.2.1 Global Paclitaxel Forecast by Regions (2019-2024)
11.2.2 Global Paclitaxel Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Paclitaxel Forecast by Type
11.8 Global Paclitaxel Forecast by Application
12 Key Players Analysis
12.1 Phyton
12.1.1 Company Details
12.1.2 Paclitaxel Product Offered
12.1.3 Phyton Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Phyton News
12.2 ScinoPharm
12.2.1 Company Details
12.2.2 Paclitaxel Product Offered
12.2.3 ScinoPharm Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 ScinoPharm News
12.3 Novasep
12.3.1 Company Details
12.3.2 Paclitaxel Product Offered
12.3.3 Novasep Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Novasep News
12.4 Samyang
12.4.1 Company Details
12.4.2 Paclitaxel Product Offered
12.4.3 Samyang Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Samyang News
12.5 Polymed
12.5.1 Company Details
12.5.2 Paclitaxel Product Offered
12.5.3 Polymed Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Polymed News
12.6 TAPI (Teva)
12.6.1 Company Details
12.6.2 Paclitaxel Product Offered
12.6.3 TAPI (Teva) Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 TAPI (Teva) News
12.7 Fresenius-kabi
12.7.1 Company Details
12.7.2 Paclitaxel Product Offered
12.7.3 Fresenius-kabi Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Fresenius-kabi News
12.8 Huiang biopharma
12.8.1 Company Details
12.8.2 Paclitaxel Product Offered
12.8.3 Huiang biopharma Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Huiang biopharma News
12.9 Southpharma
12.9.1 Company Details
12.9.2 Paclitaxel Product Offered
12.9.3 Southpharma Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Southpharma News
12.10 Yunnan Hande
12.10.1 Company Details
12.10.2 Paclitaxel Product Offered
12.10.3 Yunnan Hande Paclitaxel Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Yunnan Hande News
12.11 Hainan Yew Pharm
12.12 Jiangsu Yew Biotechnology
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Paclitaxel
Table Product Specifications of Paclitaxel
Figure Paclitaxel Report Years Considered
Figure Market Research Method
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
